Want to know more about
insurance coverage?

As you navigate your VYVGART Hytrulo treatment journey, use this guide to help you understand the insurance process and how My VYVGART Path may assist you.

Image of Insurance and Coverage Guide
Image of an NCM

Find out how My VYVGART Path helps

Explore the steps to treatment and how a dedicated Nurse Case Manager (NCM) helps guide you.

VYVGART Co-pay Program

If you have commercial or private insurance, you may be eligible for the VYVGART Co-pay Program, and may pay as little as $0 for VYVGART Hytrulo and related administration costs.*

Talk to a Nurse Case Manager at 1-833-MY-PATH-1 (1-833-697-2841) to see if you are eligible.

*Eligible commercially insured patients may pay as little as $0 for VYVGART and may receive a maximum benefit of $25,000 per calendar year for their eligible out-of-pocket costs for the drug and drug administration. Persons residing in MA and RI are not eligible for financial assistance related to administration costs. Please see full Terms and Conditions.

*Eligible commercially insured patients may pay as little as $0 for VYVGART and may receive a maximum benefit of $25,000 per calendar year for their eligible out-of-pocket costs for the drug and drug administration. Persons residing in MA and RI are not eligible for financial assistance related to administration costs. Please see full Terms and Conditions.

Cost and access

Your out-of-pocket cost for VYVGART Hytrulo may vary depending on your insurance plan. Many different factors may impact your treatment cost.

  • Your insurer’s co-pay, co-insurance, deductible, and out-of-pocket maximum requirements for medications may affect your out-of-pocket costs.
  • Where you receive treatment, your site of care, and whether your provider or specialty pharmacy is in network may also affect your out-of-pocket costs.

Understanding your insurance

Getting started on treatment and navigating insurance can feel complicated. Expand each term to learn more about the basics of health insurance.

Medicare is a federal insurance program for adults aged 65 years or older. Younger individuals with certain types of disabilities or permanent kidney failure may also qualify.

Medicare may cover treatments for FDA-approved indications. This insurance program has 4 parts (A, B, C, and D), each providing a specific type of coverage.

  • Medicare Part A covers inpatient hospital stays, care in a skilled nursing facility, hospice care, and some home healthcare
  • Medicare Part B helps cover doctors’ and other healthcare providers’ services, outpatient care, home healthcare, durable medical equipment, and many preventive services
  • Medicare Part C (Medicare Advantage) is a Medicare-approved plan from a private company that offers an alternative to Original Medicare for your health and drug coverage. These “bundled” plans include Part A, Part B, and usually Part D
  • Medicare Part D helps cover the cost of prescription drugs
  • Medicare Supplement Insurance (Medigap) is extra insurance you can buy from a private company that helps pay your share of costs in Original Medicare. Generally, you must have Original Medicare—Part A and Part B—to buy a Medigap policy

Medicaid is a health insurance program that is administered by the government. Medicaid may provide coverage for families with low income, individuals who are pregnant, older adults, and people with disabilities. Each state has different eligibility rules.

Commercial insurance, also called private insurance, is provided and administered by a private insurance company. You may receive this insurance from your employer or purchase it from the Health Insurance Marketplace.

A summary of benefits is a short, plain-language summary about a health plan’s benefits and coverage. You can use it to compare the benefits and cost of different insurance plans.

Most insurance companies need to pre-approve specific healthcare services, prescriptions, or equipment before you can receive it. This process for getting approval is called a prior authorization (pre-authorization).

Each insurance company’s timeline for the VYVGART Hytrulo prior authorization process may vary. Medicare does not require prior authorization. Reach out to an NCM if you have questions about the process or need an update.

Golfers on a golf course, pretending to be in a rock band

NOW APPROVED for self‑injection

With the VYVGART Hytrulo prefilled syringe, you can self-inject in about 20-30 seconds, once weekly—so more of the day can be yours to rock out. That's living VYVIDLY™.

†Please see Patient Information. Follow appropriate administration steps in the Instructions for Use. Monitor for signs and symptoms of an allergic reaction for at least 30 minutes after injection. If an allergic reaction occurs, you should seek medical attention.

MVP logo

Enroll in My VYVGART Path

There are 2 options to enroll once your doctor has prescribed you VYVGART Hytrulo:

Option 1

Complete the My VYVGART Path enrollment form.

Option 2

Speak with your doctor and ask to be enrolled in My VYVGART Path.

Once enrolled in My VYVGART Path, you will receive a call from an NCM to welcome you into the program. A welcome kit will be mailed to you that includes a wide range of helpful resources.

Resources to help you navigate the insurance process

VYVGART Co-pay Program brochure

If you have commercial or private insurance, you may be eligible for assistance through the VYVGART Co-pay Program.

My VYVGART Path Patient Support Program

See the different ways an NCM can support you when you enroll in My VYVGART Path.

What’s Next Guide

The What’s Next? Guide outlines next steps as you begin your journey with VYVGART Hytrulo.


Have questions? Call 1-833-VYV-CIDP (1-833-898-2437) to speak with an educator about CIDP, how VYVGART Hytrulo works, study results, cost and coverage, and more.

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • hives
    • trouble breathing
    • low blood pressure
    • fainting
  • Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • hives
    • trouble breathing
    • low blood pressure
    • fainting
  • Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.